{{Rsnum
|rsid=1320267
|Chromosome=4
|position=126012137
|Orientation=plus
|GMAF=0.4183
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 16.9 | 52.3 | 30.8
| HCB | 18.2 | 43.2 | 38.6
| JPT | 33.3 | 47.6 | 19.0
| YRI | 17.5 | 54.0 | 28.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 18.2 | 43.2 | 38.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=17903303
|Trait=Other subclinical atherosclerosis traits
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study
|RiskAllele=
|Pval=0.0000069999999999999999
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1320267
|overall_frequency_n=50
|overall_frequency_d=124
|overall_frequency=0.403226
|n_genomes=35
|n_genomes_annotated=0
|n_haplomes=42
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}